In turn, the impact of cabergoline on glucose homeostasis, plasma lipids and non-lipid risk factors was more pronounced in young women with mild or moderate hyperprolactinemia and normal vitamin D homeostasis than in age- and prolactin concentration-matched women with vitamin D deficiency [21]. The gene discussed is PRL; the disease is vitamin D deficiency.